Literature DB >> 22153350

Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging.

Yonggang Ma1, Ying Ann Chiao, Jianhua Zhang, Anne M Manicone, Yu-Fang Jin, Merry L Lindsey.   

Abstract

To determine if matrix metalloproteinase (MMP)-28 mediates cardiac aging, wild-type (WT) and MMP-28-/- young (7 ± 1 months, n = 9 each) and old (20 ± 2 months, n = 7 each) female mice were evaluated. MMP-28 expression in the left ventricle (LV) increased 42% in old WT mice compared to young controls (p < 0.05). By Doppler echocardiography, LV function declined at 20 ± 2 months of age for both groups. However, dobutamine stress responses were similar, indicating that cardiac reserve was maintained. Plasma proteomic profiling revealed that macrophage inflammatory protein (MIP)-1 α, MIP-1β and MMP-9 plasma levels did not change in WT old mice but were significantly elevated in MMP-28-/- old mice (all p < 0.05), suggestive of a higher inflammatory status when MMP-28 is deleted. RT2-PCR gene array and immunoblotting analyses demonstrated that MIP-1α and MMP-9 gene and protein levels in the LV were also higher in MMP-28-/- old mice (all p < 0.05). Macrophage numbers in the LV increased similarly in WT and MMP-28-/- old mice, compared to respective young controls (both p < 0.05). Collagen content was not different among the WT and MMP-28-/- young and old mice. In conclusion, LV inflammation increases with age, and MMP-28 deletion further elevates inflammation and extracellular matrix responses, without altering macrophage numbers or collagen content.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22153350      PMCID: PMC3972008          DOI: 10.1017/S1431927611012220

Source DB:  PubMed          Journal:  Microsc Microanal        ISSN: 1431-9276            Impact factor:   4.127


  38 in total

1.  MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors.

Authors:  G N Marchenko; A Y Strongin
Journal:  Gene       Date:  2001-03-07       Impact factor: 3.688

Review 2.  Extracellular matrix remodeling following myocardial injury.

Authors:  Merry L Lindsey; Douglas L Mann; Mark L Entman; Francis G Spinale
Journal:  Ann Med       Date:  2003       Impact factor: 4.709

3.  Methamphetamine and HIV-1 gp120 effects on lipopolysaccharide stimulated matrix metalloproteinase-9 production by human monocyte-derived macrophages.

Authors:  Jessica L Reynolds; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Stanley A Schwartz
Journal:  Immunol Invest       Date:  2011-03-22       Impact factor: 3.657

4.  Pulsed Doppler signal processing for use in mice: applications.

Authors:  Anilkumar K Reddy; George E Taffet; Yi-Heng Li; Sang-Wook Lim; Thuy T Pham; Jennifer S Pocius; Mark L Entman; Lloyd H Michael; Craig J Hartley
Journal:  IEEE Trans Biomed Eng       Date:  2005-10       Impact factor: 4.538

Review 5.  The role of inflammatory and fibrogenic pathways in heart failure associated with aging.

Authors:  Wei Chen; Nikolaos G Frangogiannis
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

6.  Effect of in vitro mechanical compression on Epilysin (matrix metalloproteinase-28) expression in hypertrophic scars.

Authors:  Filippo Renò; Maurizio Sabbatini; Maurizio Stella; Gilberto Magliacani; Mario Cannas
Journal:  Wound Repair Regen       Date:  2005 May-Jun       Impact factor: 3.617

Review 7.  Chemokines in the ischemic myocardium: from inflammation to fibrosis.

Authors:  N G Frangogiannis
Journal:  Inflamm Res       Date:  2004-11       Impact factor: 4.575

8.  Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.

Authors:  Christopher M Overall; Eric M Tam; Reinhild Kappelhoff; Andrea Connor; Tom Ewart; Charlotte J Morrison; Xose Puente; Carlos López-Otín; Arun Seth
Journal:  Biol Chem       Date:  2004-06       Impact factor: 3.915

9.  Cardiac function in young and old Little mice.

Authors:  Anilkumar K Reddy; Daniel Amador-Noguez; Gretchen J Darlington; Beth A Scholz; Lloyd H Michael; Craig J Hartley; Mark L Entman; George E Taffet
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-12       Impact factor: 6.053

10.  Expression profiling of metalloproteinases and their inhibitors in cartilage.

Authors:  Lara Kevorkian; David A Young; Clare Darrah; Simon T Donell; Lee Shepstone; Sarah Porter; Sarah M V Brockbank; Dylan R Edwards; Andrew E Parker; Ian M Clark
Journal:  Arthritis Rheum       Date:  2004-01
View more
  33 in total

1.  Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction.

Authors:  Andriy Yabluchanskiy; Yonggang Ma; Ying Ann Chiao; Elizabeth F Lopez; Andrew P Voorhees; Hiroe Toba; Michael E Hall; Hai-Chao Han; Merry L Lindsey; Yu-Fang Jin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-21       Impact factor: 4.733

2.  Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence.

Authors:  Yonggang Ma; Ying Ann Chiao; Ryan Clark; Elizabeth R Flynn; Andriy Yabluchanskiy; Omid Ghasemi; Fouad Zouein; Merry L Lindsey; Yu-Fang Jin
Journal:  Cardiovasc Res       Date:  2015-04-15       Impact factor: 10.787

Review 3.  The history of matrix metalloproteinases: milestones, myths, and misperceptions.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Gregg B Fields; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

4.  Defining the sham environment for post-myocardial infarction studies in mice.

Authors:  Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Presley L Cannon; Yonggang Ma; Kristine Y DeLeon-Pennell; Mira Jung; Elizabeth R Flynn; Jeffrey B Henry; Dustin R Bratton; Jared A White; Linda K Fulton; Andrew W Grady; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-08-12       Impact factor: 4.733

5.  Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.

Authors:  Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Nicolle L Patterson; Manishabrata Bhowmick; Elizabeth R Flynn; Majdouline Asher; Presley L Cannon; Kristine Y Deleon-Pennell; Gregg B Fields; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2016-10-13       Impact factor: 5.000

6.  Citrate synthase is a novel in vivo matrix metalloproteinase-9 substrate that regulates mitochondrial function in the postmyocardial infarction left ventricle.

Authors:  Lisandra E de Castro Brás; Courtney A Cates; Kristine Y DeLeon-Pennell; Yonggang Ma; Rugmani Padmanabhan Iyer; Ganesh V Halade; Andriy Yabluchanskiy; Gregg B Fields; Susan T Weintraub; Merry L Lindsey
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 7.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

Review 8.  Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates.

Authors:  Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Yu-Fang Jin; Merry L Lindsey
Journal:  Circ Res       Date:  2014-02-28       Impact factor: 17.367

Review 9.  Matrix metalloproteinases: drug targets for myocardial infarction.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

10.  MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosis.

Authors:  Sina A Gharib; Laura K Johnston; Isham Huizar; Timothy P Birkland; Josiah Hanson; Ying Wang; William C Parks; Anne M Manicone
Journal:  J Leukoc Biol       Date:  2013-08-20       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.